Enrico Ciferri
Enrico Ciferri publishes mostly in Surgery, Oncology and Pulmonary and Respiratory Medicine, on topics such as Colorectal Cancer Treatments and Studies, Hepatocellular Carcinoma Treatment and Prognosis and Colorectal Cancer Surgical Treatments.
- World rank
- #4,695,954 of 7,710,434 ranked researchers
- Rank in United States
- #1,237,196 of 1,627,098
- Works
- 24
- Citations
- 210
- Citations per work
- 8.8
What does Enrico Ciferri research?
Enrico Ciferri's work is mostly in Medicine (85%), Biochemistry, Genetics and Molecular Biology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2085.0%
- Medicine2085.0%
- Everything else311.7%
- Life Sciences13.3%
- 1Surgery33% of their works
- 2Oncology28% of their works
- 3Pulmonary and Respiratory Medicine10% of their works
- 4Hepatology7% of their works
- 5Pathology and Forensic Medicine7% of their works
- 6Biotechnology3% of their works
Research topics
- Colorectal Cancer Treatments and Studies
- Hepatocellular Carcinoma Treatment and Prognosis
- Colorectal Cancer Surgical Treatments
- Gallbladder and Bile Duct Disorders
- Pancreatic and Hepatic Oncology Research
- Genetic factors in colorectal cancer
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Anorectal Disease Treatments and Outcomes
Which keywords describe Enrico Ciferri's research?
The keywords of their largest research topics: Chemotherapy, Clinical Practice Guidelines, Adjuvant Chemotherapy, Cholangiocarcinoma, Neoadjuvant Therapy, Cetuximab, KRAS Mutations and Cholecystitis.
- Pancreatic Cancer
- Microsatellite Instability
- Hemorrhoids
- Biliary Tract Cancer
- Preoperative Chemoradiotherapy
- Hepatocellular Carcinoma
- Cholecystitis
- Cetuximab
- Cholangiocarcinoma
- Clinical Practice Guidelines
- Chemotherapy
- Adjuvant Chemotherapy
- Neoadjuvant Therapy
- KRAS Mutations
- ERCP
- Liver Cancer
- Rectal Cancer
- Fistulas
- Intrahepatic Cholangiocarcinoma
- Molecular Characterization
- Surgical Complications
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Chemotherapy92 topics
- Clinical Practice Guidelines82 topics
- Adjuvant Chemotherapy72 topics
- Cholangiocarcinoma72 topics
- Neoadjuvant Therapy72 topics
- Cetuximab61 topic
- KRAS Mutations61 topic
- Cholecystitis41 topic
- ERCP41 topic
- Hepatocellular Carcinoma41 topic
- Liver Cancer41 topic
- Preoperative Chemoradiotherapy41 topic
- Rectal Cancer41 topic
- Biliary Tract Cancer31 topic
- Fistulas31 topic
- Hemorrhoids31 topic
- Intrahepatic Cholangiocarcinoma31 topic
- Microsatellite Instability31 topic
- Molecular Characterization31 topic
- Pancreatic Cancer31 topic
- Surgical Complications31 topic
Where does Enrico Ciferri work?
Enrico Ciferri's main affiliation in the publication record is Martin University, United States.
How many publications and citations does Enrico Ciferri have?
OpenAlex counts 24 works and 210 citations for Enrico Ciferri, an h-index of 10, ranking #4,695,954 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Enrico Ciferri. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.